We confirmed these results by qRT-PCR in enriched monocytes from TD volunteers and showed that PTGS2 (COX-2) transcripts did not increase during ToD (Supplementary Figure 3E). The gene discussed is PTGS2; the disease is terminal osseous dysplasia-pigmentary defects syndrome.